Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€34.80

€34.80

2.960%
1.0
2.960%
€46.57
 
11.12.25 / Frankfurt WKN: A0ES9W / Symbol: ATRC / Name: AtriCure / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Financial data and news for AtriCure

sharewise wants to provide you with the best news and tools for AtriCure, so we directly link to the best financial data sources.

News

Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/1a599f395be31e2f508c3aa7decb988f9ce983b7-1401x1251.png?w=1401&h=1251
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?

Sven Wehrwein, a member of the Board of Directors at AtriCure (NASDAQ:ATRC), exercised 10,000 non-qualified stock options and immediately sold the underlying shares in derivative transactions on

AtriCure (ATRC) Q2 Revenue Jumps 17%
AtriCure (ATRC) Q2 Revenue Jumps 17%

AtriCure (NASDAQ:ATRC), a medical device company specializing in cardiac surgical technologies, delivered its earnings release on July 29, 2025, reporting results that outpaced Wall Street consensus